$10 billion in revenue by the end of the decade
The pandemic has fueled a boom in home delivery, with experts predicting that the number of delivery vehicles in the largest 100 cities around the world will increase by 36 percent over the next decade. More trucks equal more tailpipe pollution, at least 36 percent or 6 million tons,. Getting the carbon emissions out of this segment will go a long way toward improving air quality and fighting climate change.
But the company has a lot of stiff competition. In addition to BrightDrop, Ford, Rivian, and Arrival are all working on their own electric vans for commercial customers. Amazon has said it would buy vans from Rivian and Stellantis, while UPS is interested in Arrival. Ford is likely to iterate on itsBrightDrop says it can see a clean balance sheet on the horizon, confirming that it is set to generate up to $10 billion in revenue and reach 20 percent profit margins by the end of the decade.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Senior Bowl 2023 Roster CommitmentsThere are a ton of seniorbowl commitments to keep up with. We've made it easy for you to see which players will be heading down to Mobile in 2023. Check it out and bookmark this page. NFLDraft | TheDraftStartsInMobile
Read more »
White House seeks $10 billion for COVID, $37.7 billion for Ukraine from CongressThe White House will also seek more money for disaster response and rebuilding in Florida, Puerto Rico and other communities impacted by extreme weather events.
Read more »
This Biotech Entrepreneur Just Raised $10 Million To Develop A Universal Flu VaccineDistributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.
Read more »
This Biotech Entrepreneur Just Raised $10 Million To Develop A Universal Flu VaccineDistributed Bio cofounder Jacob Glanville’s new venture, Centivax, just raised a seed round to lay a foundation for human trials of its promising vaccine platform.
Read more »